Adriaan Moelker

Adriaan Moelker is a seasoned leader of global, innovation-driven businesses. Before joining BRAIN Biotech AG, he held a wide variety of management positions during his 30-year career, and his particular focus has been on Biotechnology. At AB Enzymes GmbH in Darmstadt, he was Managing Director for 9 years and during that time he directed the company to double-digit profit growth whilst building a strong business development pipeline. Previously, Adriaan had spent 12 years at Genencor (today DuPont) and DSM in the enzyme business, always focusing on business and innovation management. Consequently, he has extensive global experience in all key industrial enzyme segments: Food, Feed and Technical. For the past 6 years, he ran a printing solutions business for Flint Group, where he implemented substantial strategic change and accelerated the innovation pipeline.

Adriaan holds an MBA and a bachelor’s degree from Nyenrode University in the Netherlands and has completed Executive Education modules at INSEAD, Fontainebleau (France) as well as at Harvard Business School, Boston (USA).

Adriaan Moelker was appointed as Chief Executive Officer (CEO) of BRAIN Biotech AG with effect from February 01, 2020.